glp 1 gip glucagon triple agonist retatrutide glp-1 phase 3 2025 Dual and Triple Gut Peptide Agonists Strategic Design of Triple GLP-1R/GCGR/GIPR

[DOI] [PubMed] [Google Scholar] 111.Zelniker T.A., Wiviott S.D., Raz I., Im K., Goodrich E.L., Furtado R.H.M

Iron, magnesium, selenium, and B-complex vitamins support enzymatic velocity and mitochondrial metabolic throughput [100]

Mechanism and Clinical Efficacy: Why the Dual Agonist Approach Matters Tirzepatide works by activating both GLP-1 and GIP receptorsa dual mechanism that distinguishes it from single-agonist GLP-1 agents

Inhibition of glucagon secretion

Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice

(See Fig